HIGHLIGHTS
- who: Christos Papaneophytou and collaborators from the Department of Life and Health Science, School of Sciences and Engineering, University of have published the research: Seroprevalence of immunoglobulin G antibodies against SARS-CoV-2 in Cyprus, in the Journal: PLOS ONE of 17/02/2022
- what: After this study the authors report that the plasma levels of IgG antibodies against SARS-CoV-2 spike protein were higher in individuals with evidence of prior infection who received at least one dose of either an mRNA-based vaccine (Comirnaty BNT162b2/ Pfizer-BioNTech or Spikevax mRNA-1273/Moderna) or . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.